The Clinical trials of one of the most advanced experimental Covid-19 vaccines have been re-started after a brief safety pause.
The world’s hopes for a reprieve from the pandemic were dealt a blow earlier in the week when pharmaceutical company AstraZeneca and Oxford University announced a voluntarily pause in their vaccine trial after a UK volunteer developed an unexplained illness.
However, the trial was given the all clear by British regulators following a safety review.
The global death toll from the coronavirus has risen over 916,000 with 28.5 million infections.
A worldwide race to develop a vaccine is underway with nine companies already in late-stage, Phase 3 trials.
Source: Radio Pakistan